HCA Healthcare, Inc. (HCA) Stock Forecast
US · Healthcare
Current price
$386.94
Market cap
$85.84B
Mean price target
$500.29
Implied upside
29.3%
Key takeaways
- Analysts rate HCA Healthcare, Inc. a “Buy”, with a mean price target of $500.29 — about 29.3% upside from the current $386.94, based on 21 analysts.
- HCA is trading in the middle of its 52-week range, at 25% of the $330.00–$556.52 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 21 |
| Mean target | $500.29 |
| High target | $635.00 |
| Low target | $396.00 |
| Rating split (SB / B / H / S / SS) | 2 / 13 / 9 / 1 / 0 |
Price & trading
| Current price | $386.94 |
|---|---|
| Previous close | $387.76 |
| 52-week high | $556.52 |
| 52-week low | $330.00 |
| 50-day average | $414.50 |
| Beta | 1.13 |
See the full HCA breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current HCA Healthcare, Inc. (HCA) share price?
- HCA Healthcare, Inc. last traded at $386.94 with a market capitalisation of about $85.8B.
- What is the analyst price target for HCA?
- The mean analyst price target for HCA Healthcare, Inc. is $500.29, roughly 29.3% above the latest price. The current consensus rating is “Buy”.
- Where can I see HCA Healthcare, Inc.'s full financial metrics?
- Luminoso tracks HCA's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.